2024-10-01 2025-09-30 2025-09-30 false 10383691 GDK MEDI UK LTD 2026-06-25 false iso4217:GBP xbrli:pure 10383691 2024-09-30 10383691 2025-09-30 10383691 2024-10-01 2025-09-30 10383691 2023-09-30 10383691 2024-09-30 10383691 2023-10-01 2024-09-30 10383691 bus:SmallEntities 2024-10-01 2025-09-30 10383691 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 10383691 bus:AbridgedAccounts 2024-10-01 2025-09-30 10383691 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10383691 core:WithinOneYear 2025-09-30 10383691 core:AfterOneYear 2025-09-30 10383691 core:WithinOneYear 2024-09-30 10383691 core:AfterOneYear 2024-09-30 10383691 core:ShareCapital 2025-09-30 10383691 core:SharePremium 2025-09-30 10383691 core:RevaluationReserve 2025-09-30 10383691 core:OtherReservesSubtotal 2025-09-30 10383691 core:RetainedEarningsAccumulatedLosses 2025-09-30 10383691 core:ShareCapital 2024-09-30 10383691 core:SharePremium 2024-09-30 10383691 core:RevaluationReserve 2024-09-30 10383691 core:OtherReservesSubtotal 2024-09-30 10383691 core:RetainedEarningsAccumulatedLosses 2024-09-30 10383691 core:LandBuildings 2025-09-30 10383691 core:PlantMachinery 2025-09-30 10383691 core:Vehicles 2025-09-30 10383691 core:FurnitureFittings 2025-09-30 10383691 core:OfficeEquipment 2025-09-30 10383691 core:NetGoodwill 2025-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2025-09-30 10383691 core:ListedExchangeTraded 2025-09-30 10383691 core:UnlistedNon-exchangeTraded 2025-09-30 10383691 core:LandBuildings 2024-09-30 10383691 core:PlantMachinery 2024-09-30 10383691 core:Vehicles 2024-09-30 10383691 core:FurnitureFittings 2024-09-30 10383691 core:OfficeEquipment 2024-09-30 10383691 core:NetGoodwill 2024-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2024-09-30 10383691 core:ListedExchangeTraded 2024-09-30 10383691 core:UnlistedNon-exchangeTraded 2024-09-30 10383691 core:LandBuildings 2024-10-01 2025-09-30 10383691 core:PlantMachinery 2024-10-01 2025-09-30 10383691 core:Vehicles 2024-10-01 2025-09-30 10383691 core:FurnitureFittings 2024-10-01 2025-09-30 10383691 core:OfficeEquipment 2024-10-01 2025-09-30 10383691 core:NetGoodwill 2024-10-01 2025-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2024-10-01 2025-09-30 10383691 core:ListedExchangeTraded 2024-10-01 2025-09-30 10383691 core:UnlistedNon-exchangeTraded 2024-10-01 2025-09-30 10383691 core:MoreThanFiveYears 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments 2025-09-30 10383691 core:Non-currentFinancialInstruments 2024-09-30 10383691 dpl:CostSales 2024-10-01 2025-09-30 10383691 dpl:DistributionCosts 2024-10-01 2025-09-30 10383691 core:LandBuildings 2024-10-01 2025-09-30 10383691 core:PlantMachinery 2024-10-01 2025-09-30 10383691 core:Vehicles 2024-10-01 2025-09-30 10383691 core:FurnitureFittings 2024-10-01 2025-09-30 10383691 core:OfficeEquipment 2024-10-01 2025-09-30 10383691 dpl:AdministrativeExpenses 2024-10-01 2025-09-30 10383691 core:NetGoodwill 2024-10-01 2025-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2024-10-01 2025-09-30 10383691 dpl:GroupUndertakings 2024-10-01 2025-09-30 10383691 dpl:ParticipatingInterests 2024-10-01 2025-09-30 10383691 dpl:GroupUndertakings core:ListedExchangeTraded 2024-10-01 2025-09-30 10383691 core:ListedExchangeTraded 2024-10-01 2025-09-30 10383691 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-10-01 2025-09-30 10383691 core:UnlistedNon-exchangeTraded 2024-10-01 2025-09-30 10383691 dpl:CostSales 2023-10-01 2024-09-30 10383691 dpl:DistributionCosts 2023-10-01 2024-09-30 10383691 core:LandBuildings 2023-10-01 2024-09-30 10383691 core:PlantMachinery 2023-10-01 2024-09-30 10383691 core:Vehicles 2023-10-01 2024-09-30 10383691 core:FurnitureFittings 2023-10-01 2024-09-30 10383691 core:OfficeEquipment 2023-10-01 2024-09-30 10383691 dpl:AdministrativeExpenses 2023-10-01 2024-09-30 10383691 core:NetGoodwill 2023-10-01 2024-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2023-10-01 2024-09-30 10383691 dpl:GroupUndertakings 2023-10-01 2024-09-30 10383691 dpl:ParticipatingInterests 2023-10-01 2024-09-30 10383691 dpl:GroupUndertakings core:ListedExchangeTraded 2023-10-01 2024-09-30 10383691 core:ListedExchangeTraded 2023-10-01 2024-09-30 10383691 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-10-01 2024-09-30 10383691 core:UnlistedNon-exchangeTraded 2023-10-01 2024-09-30 10383691 core:NetGoodwill 2025-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2025-09-30 10383691 core:LandBuildings 2025-09-30 10383691 core:PlantMachinery 2025-09-30 10383691 core:Vehicles 2025-09-30 10383691 core:FurnitureFittings 2025-09-30 10383691 core:OfficeEquipment 2025-09-30 10383691 core:AfterOneYear 2025-09-30 10383691 core:WithinOneYear 2025-09-30 10383691 core:ListedExchangeTraded 2025-09-30 10383691 core:UnlistedNon-exchangeTraded 2025-09-30 10383691 core:ShareCapital 2025-09-30 10383691 core:SharePremium 2025-09-30 10383691 core:RevaluationReserve 2025-09-30 10383691 core:OtherReservesSubtotal 2025-09-30 10383691 core:RetainedEarningsAccumulatedLosses 2025-09-30 10383691 core:NetGoodwill 2024-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2024-09-30 10383691 core:LandBuildings 2024-09-30 10383691 core:PlantMachinery 2024-09-30 10383691 core:Vehicles 2024-09-30 10383691 core:FurnitureFittings 2024-09-30 10383691 core:OfficeEquipment 2024-09-30 10383691 core:AfterOneYear 2024-09-30 10383691 core:WithinOneYear 2024-09-30 10383691 core:ListedExchangeTraded 2024-09-30 10383691 core:UnlistedNon-exchangeTraded 2024-09-30 10383691 core:ShareCapital 2024-09-30 10383691 core:SharePremium 2024-09-30 10383691 core:RevaluationReserve 2024-09-30 10383691 core:OtherReservesSubtotal 2024-09-30 10383691 core:RetainedEarningsAccumulatedLosses 2024-09-30 10383691 core:NetGoodwill 2023-09-30 10383691 core:IntangibleAssetsOtherThanGoodwill 2023-09-30 10383691 core:LandBuildings 2023-09-30 10383691 core:PlantMachinery 2023-09-30 10383691 core:Vehicles 2023-09-30 10383691 core:FurnitureFittings 2023-09-30 10383691 core:OfficeEquipment 2023-09-30 10383691 core:AfterOneYear 2023-09-30 10383691 core:WithinOneYear 2023-09-30 10383691 core:ListedExchangeTraded 2023-09-30 10383691 core:UnlistedNon-exchangeTraded 2023-09-30 10383691 core:ShareCapital 2023-09-30 10383691 core:SharePremium 2023-09-30 10383691 core:RevaluationReserve 2023-09-30 10383691 core:OtherReservesSubtotal 2023-09-30 10383691 core:RetainedEarningsAccumulatedLosses 2023-09-30 10383691 core:AfterOneYear 2024-10-01 2025-09-30 10383691 core:WithinOneYear 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:CostValuation 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 10383691 core:Non-currentFinancialInstruments core:CostValuation 2025-09-30 10383691 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-09-30 10383691 core:Non-currentFinancialInstruments core:CostValuation 2024-09-30 10383691 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-30 10383691 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-30 10383691 bus:Director1 2024-10-01 2025-09-30 10383691 bus:Director2 2024-10-01 2025-09-30 10383691 bus:Director3 2024-10-01 2025-09-30

GDK MEDI UK LTD

Registered Number
10383691
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2025

GDK MEDI UK LTD
Company Information
for the year from 1 October 2024 to 30 September 2025

Directors | HUANG, Anli, Ms.
| HUANG, Xiaochun
| YU, Qian

Registered Address | C/O Umc Accountants
| 314 Carshalton Road
| Carshalton
| SM5 3QB

Registered Number | 10383691 (England and Wales)

GDK MEDI UK LTD
Balance Sheet as at
30 September 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 1,008 |  |  |  | 1,344
|  |  |  | 1,008 |  |  |  | 1,344
Current assets |  |  |  |  |  |  |  |
Debtors |  | 186 |  |  |  | 137 |  |
Cash at bank and on hand |  | 144,997 |  |  |  | 172,104 |  |
|  | 145,183 |  |  |  | 172,241 |  |
Creditors amounts falling due within one year |  | (119,194) |  |  |  | (148,122) |  |
Net current assets (liabilities) |  |  |  | 25,989 |  |  |  | 24,119
Total assets less current liabilities |  |  |  | 26,997 |  |  |  | 25,463
Creditors amounts falling due after one year |  |  |  | (10,000) |  |  |  | (10,000)
Net assets |  |  |  | 16,997 |  |  |  | 15,463
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1,000 |  |  |  | 1,000
Profit and loss account |  |  |  | 15,997 |  |  |  | 14,463
Shareholders' funds |  |  |  | 16,997 |  |  |  | 15,463

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 25 June 2026, and are signed on its behalf by:
HUANG, Xiaochun Director Registered Company No. 10383691

GDK MEDI UK LTD
Notes to the Financial Statements
for the year ended 30 September 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Revenue from sale of goods
--- | ---
| Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Employee benefits
--- | ---
| Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%)
| Office Equipment | 25

| Related parties
--- | ---
| For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 3 |  | 3

3. | Tangible fixed assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 October 24 | 2,810
| At 30 September 25 | 2,810
| Depreciation and impairment
| At 01 October 24 | 1,466
| Charge for year | 336
| At 30 September 25 | 1,802
| Net book value
| At 30 September 25 | 1,008
| At 30 September 24 | 1,344

4. | Related party transactions
--- | ---
| Transactions with directors mainly arose business expenses paid on behalf of the company. The company was under the control of Ms. X Huang throughout the current and previous financial years, Ms. Huang is the managing directors and majority shareholding of the company. No transactions with related parties were undertaken such as are required to be disclosed under FRS 102 Section 1A.